Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA）
NCT07127042
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Total Knee Arthroplasty
Interventions
DRUG:
Low-dose BT-114143
DRUG:
High-dose BT-14143
DRUG:
Tranexamic Acid (IV)
Sponsor
ScinnoHub Pharmaceutical Co., Ltd.